Research in ProgressAs a medication use quality researcher, PQA is engaged in a variety of projects and initiatives related to Medication Adherence & Safety, Medication Access & Social Determinants of Health, Patient Engagement, and Pharmacy Services. PQA has more than a dozen active research projects. Focus Areas: (click on focus area to reach section)
Medication Adherence & SafetyRelationships between medication adherence, patient costs, and economic outcomesMethodology: Secondary Data Analysis Collaborators: Merck, University of Mississippi Description: This retrospective cohort study aims to describe the relationships of patient out-of-pocket costs on medication adherence and subsequent economic outcomes, describe the interplay of medication adherence quality measures and economic outcomes, and identify proportion of days covered (PDC) levels where outcomes are optimized. Reducing opioid overprescribing for common surgical proceduresMethodology: Program Implementation & Evaluation Collaborators: Johns Hopkins University Description: This prospective, Improving Wisely interventional study will evaluate the impact of an individual, provider-level peer-to-peer benchmarked opioid prescribing report intervention on opioid prescribing for common surgical procedures. Adherence to dual antiplatelet therapyMethodology: Secondary Data Analysis Collaborators: Pharmacy Quality Solutions Description: This retrospective cohort study aims to describe and compare adherence to P2Y12 inhibitors and examine factors related to adherence. Medication Access & SDOH ⇑ topPatient Engagement ⇑ topCapturing patient perspectives of comprehensive medication reviewsMethodology: Qualitative Collaborators: Merck, University of Arizona Description: This study aims to conceptualize and develop a patient-reported comprehensive medication review experience questionnaire. Pharmacy Services ⇑ topEvaluating the impact of pharmacist-provided care on medication use, health, and economic outcomesMethodology: Program implementation & evaluation Collaborators: Humana, Walgreens, Pfizer Description: This prospective, randomized study will evaluate the impact of pharmacist-provided care on medication use, health, and economic outcomes in patients with diabetes. |